159 companies

Lobe Sciences

Market Cap: CA$11.9m

A biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada.

LOBE

CA$0.045

7D

-10.0%

1Y

125.0%

TRUBAR

Market Cap: CA$80.8m

Operates as a consumer products company with diversified assets in the plant-based and wellness consumer product categories in Canada.

TRBR

CA$0.76

7D

11.8%

1Y

24.6%

Cardiol Therapeutics

Market Cap: CA$128.1m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

CRDL

CA$1.54

7D

3.7%

1Y

-38.2%

Sharp Therapeutics

Market Cap: CA$30.0m

A preclinical-stage drug discovery company, develops therapeutics for genetic diseases.

SHRX

CA$1.00

7D

0%

1Y

n/a

4Front Ventures

Market Cap: CA$4.6m

Engages in cultivating, processing, manufacturing, and sale of cannabis products in the United States.

FFNT

CA$0.005

7D

0%

1Y

-96.4%

Microbix Biosystems

Market Cap: CA$31.4m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

MBX

CA$0.23

7D

0%

1Y

-37.3%

Cytophage Technologies

Market Cap: CA$16.0m

A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.

CYTO

CA$0.25

7D

0%

1Y

-12.3%

CanadaBis Capital

Market Cap: CA$5.5m

Engages in the production and sale of recreational cannabis and cannabis extracts in Canada.

CANB

CA$0.04

7D

-11.1%

1Y

-33.3%

MindBio Therapeutics

Market Cap: CA$6.8m

Operates as a clinical stage drug development company in Australasia.

MBIO

CA$0.01

7D

100.0%

1Y

-66.7%

Adastra Holdings

Market Cap: CA$1.2m

Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada.

XTRX

CA$0.21

7D

-14.0%

1Y

-74.7%

Kane Biotech

Market Cap: CA$6.6m

A biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally.

KNE

CA$0.04

7D

-5.9%

1Y

-66.7%

Aptose Biosciences

Market Cap: CA$4.2m

A clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States.

APS

CA$1.65

7D

-2.4%

1Y

-89.4%

Appili Therapeutics

Market Cap: CA$1.8m

A biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada.

APLI

CA$0.015

7D

-25.0%

1Y

-50.0%

Onco-Innovations

Market Cap: CA$99.3m

A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

ONCO

CA$1.95

7D

5.4%

1Y

n/a

EGF Theramed Health

Market Cap: CA$929.3k

Engages in the development of psychedelic drugs for the treatment of mental health problems in Canada.

TMED

CA$0.08

7D

0%

1Y

n/a

Quest PharmaTech

Market Cap: CA$5.9m

A pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer.

QPT

CA$0.035

7D

-12.5%

1Y

40.0%

HAVN Life Sciences

Market Cap: CA$859.4k

A biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi.

HAVN

n/a

7D

n/a

1Y

n/a

Ayr Wellness

Market Cap: CA$18.1m

Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods.

AYR.A

CA$0.15

7D

0%

1Y

-93.6%

Mountain Valley MD Holdings

Market Cap: CA$5.3m

A biotech company, focused on advancing solutions to optimize human, animal, and plant health in Canada.

MVMD

CA$0.02

7D

0%

1Y

-42.9%

Waverley Pharma

Market Cap: CA$810.0k

A biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom.

WAVE

CA$0.015

7D

0%

1Y

n/a

Revive Therapeutics

Market Cap: CA$8.6m

A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.

RVV

CA$0.02

7D

0%

1Y

100.0%

Street Capital

Market Cap: CA$1.4m

Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.

STRC.X

CA$0.005

7D

0%

1Y

0%

BioVaxys Technology

Market Cap: CA$8.8m

A clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.

BIOV

CA$0.025

7D

-16.7%

1Y

-58.3%

FLUENT

Market Cap: US$38.0m

Through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.

FNT.U

US$0.06

7D

0%

1Y

-63.6%

HLS Therapeutics

Market Cap: CA$173.6m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.

HLS

CA$5.45

7D

1.7%

1Y

70.3%

FinCanna Capital

Market Cap: CA$5.0m

Does not have significant operations.

CALI.X

CA$0.005

7D

0%

1Y

0%

Blueberries Medical

Market Cap: CA$7.4m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

BBM

CA$0.015

7D

-25.0%

1Y

-25.0%

StageZero Life Sciences

Market Cap: CA$4.9m

A vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.

SZLS

CA$0.04

7D

0%

1Y

-27.3%

Hemostemix

Market Cap: CA$19.0m

A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.

HEM

CA$0.10

7D

-4.5%

1Y

40.0%

Aion Therapeutic

Market Cap: CA$2.5m

Engages in the health and wellness business in the United States.

AION

CA$0.005

7D

0%

1Y

-50.0%

Lophos Holdings

Market Cap: CA$858.6k

Through its subsidiaries, engages in the cultivation and research of peyote cactus.

MESC

CA$0.01

7D

0%

1Y

-75.0%

Lowell Farms

Market Cap: CA$272.2k

Engages in the cultivation, extraction, processing, manufacturing, branding, packaging, and wholesale distribution of cannabis products to retail dispensaries in California.

LOWL

CA$0.015

7D

0%

1Y

-57.1%

Helix BioPharma

Market Cap: CA$106.9m

Operates as an immune-oncology company in Canada.

HBP

CA$1.45

7D

6.6%

1Y

11.5%

Marvel Biosciences

Market Cap: CA$12.5m

A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.

MRVL

CA$0.27

7D

-6.9%

1Y

125.0%

Herbal Dispatch

Market Cap: CA$4.9m

Owns and operates cannabis e-commerce platforms in Canada and the United States.

HERB

CA$0.06

7D

-29.4%

1Y

20.0%

Aequus Pharmaceuticals

Market Cap: CA$663.2k

Operates as a specialty pharmaceutical company in Canada.

AQS

CA$0.005

7D

0%

1Y

-80.0%

Page 3 of 5